Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer
Clinical trial NCT04922658 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04922658
- Sponsor
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-03
- Primary completion
- 2025-12-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.